Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.152
+0.002 (0.17%)
At close: Feb 27, 2026, 4:00 PM EST
1.150
-0.002 (-0.17%)
After-hours: Feb 27, 2026, 6:11 PM EST
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $2.07 million as of February 27, 2026. Its market cap has decreased by -21.54% in one year.
Market Cap
2.07M
Enterprise Value
-3.98M
1-Year Change
-21.54%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $2.07M, a decrease of -98.67%. That is a compound annual growth rate of -35.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 2.07M | -20.55% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SciSparc | 2.98M |
| Psyence Biomedical | 2.96M |
| Adial Pharmaceuticals | 2.81M |
| Artelo Biosciences | 2.50M |
| XORTX Therapeutics | 2.49M |
| Clearmind Medicine | 2.03M |
| Lyra Therapeutics | 1.99M |
| CNS Pharmaceuticals | 1.90M |